Your Location：
Home >
Browse articles >
Shenling Baizhusan Alleviates Intestinal Inflammation in Rat Model of Crohn's Disease via p38 MAPK Pathway
Shenling Baizhusan Alleviates Intestinal Inflammation in Rat Model of Crohn's Disease via p38 MAPK Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 19, Pages: 9-17(2023)
DOI： 10.13422/j.cnki.syfjx.20230716
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 8 )
References
Publication Info
Metrics
303
Views
135
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Improvement of Emotional State of Rats with Diarrhea-predominant Irritable Bowel Syndrome by Shenling Baizhusan with Codonopsis Radix as Monarch Drug
Based on 16S rDNA Technology and TLRs/MyD88/NF-κB Signaling Pathway， Molecular Mechanism of Shenling Baizhusan Resistance to Diarrhea Irritable Bowel Syndrome Rats Was Investigated
Research Progress on Pathogenesis of Ankylosing Spondylitis and Intervention of Traditional Chinese Medicine： A Review
Traditional Chinese Medicine Intervention for Ferroptosis in Treatment of Inflammatory Bowel Disease： A Review
Clinical Efficacy of Modified Banxia Xiexintang Combined with Vedolizumab in Treatment of Crohn's Disease with Syndrome of Cold and Heat in Complexity
Related Author
HAN Guanghui
WU Wenyu
LIU Jiabao
ZHANG Xueping
YANG Yang
LIANG Kun
WEI Wei
LYU Tengfei
Related Institution
Wangjing Hospital， China Academy of Chinese Medical Sciences
Henan University of Chinese Medicine School of Management
The Second Clinical Medical College of Henan University of Traditional Chinese Medicine
Gansu University of Traditional Chinese Medicine （TCM）
Gansu Provincial Hospital of TCM Rheumatism Osteopathy Center
Chat
